Advances in Functionalized Hydrogels in the Treatment of Myocardial Infarction and Drug-Delivery Strategies
ACS Applied Materials & Interfaces · 18.09.2024 · 16 (37) · 48880-48894
DOI: 10.1021/acsami.4c09623 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 03.09.2024. Verfasst von Yuchen Cao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, Chi…. Hauptthemen laut MEDLINE: Hydrogels, Myocardial Infarction, Drug Delivery Systems. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 140 Literaturangaben. Gefördert von: Natural Science Foundation of Shanxi Province, Shanxi Traditional Chinese Medicine Administration, Shanxi Bethune Hospital.
Abstract (Originalsprache)
Myocardial infarction (MI) is a serious cardiovascular disease with high morbidity and mortality rates, posing a significant threat to patient's health and quality of life. Following a MI, the damaged myocardial tissue is typically not fully repaired, leading to permanent impairment of myocardial function. While traditional treatments can alleviate symptoms and reduce pain, their ability to repair damaged heart muscle tissue is limited. Functionalized hydrogels, a broad category of materials with diverse functionalities, can enhance the properties of hydrogels to cater to the needs of tissue engineering, drug delivery, medical dressings, and other applications. Recently, functionalized hydrogels have emerged as a promising new therapeutic approach for the treatment of MI. Functionalized hydrogels possess outstanding biocompatibility, customizable mechanical properties, and drug-release capabilities. These properties enable them to offer scaffold support, drug release, and tissue regeneration promotion, making them a promising approach for treating MI. This paper aims to evaluate the advancements and delivery methods of functionalized hydrogels for treating MI, while also discussing their potential and the challenges they may pose for future clinical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China.
- Shanxi Academy of Advanced Research and Innovation, Taiyuan 030032, China.
- Key Laboratory of Cellular Physiology (Shanxi Medical University), Ministry of Education, Taiyuan 030032, China.
- Key Laboratory of Cellular Physiology, Shanxi Province, Taiyuan 030032, China.
ORCID-Profile: Yuchen Cao
Förderung
- Natural Science Foundation of Shanxi Province
- Shanxi Traditional Chinese Medicine Administration
- Shanxi Bethune Hospital
Zitieren
APA
Cao, Y., Fan, R., Zhu, K., & Gao, Y. (2024). Advances in Functionalized Hydrogels in the Treatment of Myocardial Infarction and Drug-Delivery Strategies. ACS Applied Materials & Interfaces, 16(37), 48880-48894. https://doi.org/10.1021/acsami.4c09623
Vancouver
Cao Y, Fan R, Zhu K, Gao Y. Advances in Functionalized Hydrogels in the Treatment of Myocardial Infarction and Drug-Delivery Strategies. ACS Applied Materials & Interfaces. 2024;16(37):48880-48894. doi:10.1021/acsami.4c09623
BibTeX
@article{Cao2024,
author = {Cao, Yuchen and Fan, Rong and Zhu, Kaiyi and Gao, Yuping},
title = {Advances in Functionalized Hydrogels in the Treatment of Myocardial Infarction and Drug-Delivery Strategies},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
volume = {16},
number = {37},
pages = {48880--48894},
doi = {10.1021/acsami.4c09623}
}
EUVIMED